SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IART

Integra Lifesciences Holdings Corp (NASDAQ:IART)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$13.25-$0.30 (-2.21%)
 
Market cap
$1.03B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 16, 1995
Market Cap$1.03B+10.1%
Revenue (ttm)$1.66B+0.8%
Net Income$13.01M+102.6%
EPS$0.17+102.6%
Shares Out77.80M
PE Ratio78.96
Forward PE5.59
Dividendn/a
Ex-Dividend Daten/a
Volume826,614
Open$13.38
Previous Close$13.55
Day's Range$13.16 - $13.79
52-Week Range$8.70 - $20.49
Beta1.28
AnalystsBuy
Price Target$16.43(+24.00%)
Earnings DateFeb 25, 2027

About IART

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Address
1100 Campus Road, Princeton, NJ, 08540, US
Market Cap
1.03 billion
Employees
4,427
Industrial Classification
Medical - Devices

Analyst consensus

Hold
1 Buy5 Hold1 SellAvg target $15.60 (+15.7%)

7 firms rating IART in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From IART’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.21%
5 Days
-7.34%
1 Month
+11.91%
6 Months
-12.37%
1 Year
+10.05%

$IART stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of IART by members of U.S. Congress

Josh GottheimerHouse / DSale$1.00K – $15.00KJun 18, 2024
Josh GottheimerHouse / DSale$1.00K – $15.00KApr 5, 2024
Josh GottheimerHouse / DPurchase$1.00K – $15.00KOct 16, 2023
Josh GottheimerHouse / DSale$1.00K – $15.00KSep 15, 2023
Josh GottheimerHouse / DSale$1.00K – $15.00KJun 13, 2023
Josh GottheimerHouse / DPurchase$1.00K – $15.00KOct 16, 2020
Josh GottheimerHouse / DSale$1.00K – $15.00KSep 15, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 10, 2020

Recently reported changes in IART holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by IART's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

IART Estimated quarterly lobbying spending

Source: U.S. Senate LDA

IART Revenue by Segment or Geography

$411.18MTotal
Specialty Surgery$304.12M73.96%
Tissue Reconstruction$107.06M26.04%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New IART patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to IART from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in IART

IJRiShares Core S&P Small-Cap ETF$53.96M
IWMiShares Russell 2000 ETF$24.02M
VTIVanguard Morningstar Total Stock Market ETF$21.09M
VBVanguard Morningstar Small-Cap ETF$18.93M
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$15.38M
VBRVanguard Morningstar Small-Cap Value ETF$12.27M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from IART’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
56
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHEState Street SPDR S&P Health Care Equipment ETF1.34%
IBRNiShares Neuroscience and Healthcare ETF1.05%
HTECROBO Global Healthcare Technology and Innovation ETF1.05%
NIXTResearch Affiliates Deletions ETF0.60%
VFLQVanguard U.S. Liquidity Factor ETF0.55%
PSCHInvesco S&P SmallCap Health Care ETF0.51%
QQQSInvesco NASDAQ Future Gen 200 ETF0.49%
FYTFirst Trust Small Cap Value AlphaDEX Fund0.21%
SQLVRoyce Quant Small-Cap Quality Value ETF0.21%
EESWisdomTree U.S. SmallCap Fund0.20%
VVL.TOVanguard Global Value Factor ETF0.19%
DMRMDeltaShares S&P 400 Managed Risk ETF0.19%

Weight is the stock’s share of each fund’s holdings.